arrow
Back
T

Tove Kirkegaard

Zealand University Hospital

19H-index
77Paper Count
2.1KCitation Count
Published Papers 17
Publication Date
Highly sensitive luciferase-based assay with red fluorescent protein expression for accurate quantitative monitoring and real-time visualization of cell invasion
err2025-09-27
err0
PREAI
errMichael Lyngbæk Christensen; Tove Kirkegaard; Ismail Gögenur; Frederik Diness; Jesper Thorvald Troelsen; Stine Bull Jessen
errShare
errSave
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
err2021-01-04
err11
errOAAI
errLokkegaard, Sanne; Elias, Daniel; Alves, Carla L.; Bennetzen, Martin V.; Laenkholm, Anne-Vibeke; Bak, Martin; Gjerstorff, Morten F.; Johansen, Lene E.; Vever, Henriette; Bjerre, Christina; Kirkegaard, Tove; Nordenskjoeld, Bo; Fornander, Tommy; Stal, Olle; Lindstroem, Linda S.; Esserman, Laura J.; Lykkesfeldt, Anne E.; Andersen, Jens S.; Leth-Larsen, Rikke; Ditzel, Henrik J.
errShare
errSave
CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells
err2020-05-14
err3
errOAAI
errDavidsen, Johanne; Jessen, Stine Bull; Watt, Sara Kehlet; Larsen, Sylvester; Dahlgaard, Katja; Kirkegaard, Tove; Gogenur, Ismail; Troelsen, Jesper T.
errShare
errSave
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast Cancer
err2016-11-14
err52
errOAAI
errAlves, Carla L.; Elias, Daniel; Lyng, Maria; Bak, Martin; Kirkegaard, Tove; Lykkesfeldt, Anne E.; Ditzel, Henrik J.
errShare
errSave
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
err2015-04-08
err22
errOAAI
errLarsen, Sarah L.; Yde, Christina W.; Laenkholm, Anne-Vibeke; Rasmussen, Birgitte B.; Duun-Henriksen, Anne Katrine; Bak, Martin; Lykkesfeldt, Anne E.; Kirkegaard, Tove
errShare
errSave
T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant
err2014-03-01
err26
PREAI
errKirkegaard, Tove; Hansen, Susanne K.; Larsen, Sarah L.; Reiter, Birgit E.; Sorensen, Boe S.; Lykkesfeldt, Anne E.
errShare
errSave
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH
err2009-12-23
err50
PREAI
errKirkegaard, Tove; Witton, Caroline J.; Edwards, Joanne; Nielsen, Kirsten Vang; Jensen, Linda Boye; Campbell, Fiona M.; Cooke, Timothy G.; Bartlett, John M. S.
errShare
errSave
Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance
err2009-08-21
err32
errOAAI
errSonne-Hansen, Katrine; Norrie, Ida C.; Emdal, Kristina B.; Benjaminsen, Rikke V.; Frogne, Thomas; Christiansen, Ib J.; Kirkegaard, Tove; Lykkesfeldt, Anne E.
errShare
errSave
Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients
err2009-02-19
err82
errOAAI
errMcGlynn, Liane M.; Kirkegaard, Tove; Edwards, Joanne; Tovey, Sian; Cameron, David; Twelves, Chris; Bartlett, John M. S.; Cooke, Timothy G.
errShare
errSave
Amplified in breast cancer 1 in human epidermal growth factor receptor-positive tumors of tamoxifen-treated breast cancer patients
err2007-03-01
err101
PREAI
errKirkegaard, Tove; McGlynn, Liane M.; Campbell, Fiona M.; Mueller, Sven; Tovey, Sian M.; Dunne, Barbara; Nielsen, Kirsten V.; Cooke, Timothy G.; Bartlett, John M. S.
errShare
errSave
Bad expression predicts outcome in patients treated with tamoxifen
err2006-09-27
err42
PREAI
errCannings, Elizabeth; Kirkegaard, Tove; Tovey, Sian M.; Dunne, Barbara; Cooke, T. G.; Bartlett, John M. S.
errShare
errSave
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
err2005-08-09
err268
PREAI
errKirkegaard, T; Witton, CJ; McGlynn, LM; Tovey, SM; Dunne, B; Lyon, A; Bartlett, JMS
errShare
errSave
A scrutiny of matrix metalloproteinases in osteoclasts:: evidence for heterogeneity and for the presence of MMPs synthesized by other cells
errBONE
IF3.6
err2004-11-01
err141
PREAI
errAndersen, TL; Ovejero, MD; Kirkegaard, T; Lenhard, T; Foged, NT; Delaissé, JM
errShare
errSave
Transforming growth factor-β controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression
err2003-11-01
err138
errOAAI
errKarsdal, MA; Hjorth, P; Henriksen, K; Kirkegaard, T; Nielsen, KL; Lou, H; Delaissé, JM; Foged, NT
errShare
errSave
errShare
errSave
Proteinases in bone resorption:: obvious and less obvious roles
err2000-02-01
err191
PREAI
errDelaissé, JM; Engsig, MT; Everts, V; Ovejero, MD; Ferreras, M; Lund, L; Vu, TH; Werb, Z; Winding, B; Lochter, A; Karsdal, MA; Troen, T; Kirkegaard, T; Lenhard, T; Heegaard, AM; Neff, L; Baron, R; Foged, NT
errShare
errSave
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
err1997-05-01
err222
PREAI
errKjoller, L; Kanse, SM; Kirkegaard, T; Rodenburg, KW; Ronne, E; Goodman, SL; Preissner, KT; Ossowski, L; Andreasen, PA
errShare
errSave